Repligen | RGEN - Trade Debtors


Repligen reported $157.71M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Agilent USD 1.5B 23M Mar/2026
Align Technology USD 1.15B 23.28M Jun/2026
Bio Techne USD 214.56M 29.95M Mar/2026
BioMarin Pharmaceutical USD 1.06B 157.13M Jun/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Bruker USD 545.9M 3.2M Jun/2026
Charles River Laboratories USD 711.76M 11.5M Jun/2026
Danaher USD 4.96B 205M Jun/2026
Dentsply International USD 620M 2M Jun/2026
General Electric Aerospace USD 22.36B 186M Jun/2026
Henry Schein USD 1.76B 44M Jun/2026
Illumina USD 764M 26M Jun/2026
IQVIA Holdings USD 3.39B 12M Jun/2026
Mettler Toledo International USD 731.48M 23.27M Jun/2026
Myriad Genetics USD 115.3M 2.7M Dec/2025
OraSure Technologies USD 22.2M 2.1M Dec/2025
Pacific Biosciences Of California USD 35.45M 4.83M Dec/2025
Pfizer USD 16.19B 19M Jun/2026
Repligen USD 157.71M 6.16M Jun/2026
Revvity USD 709.18M 17.79M Jun/2026
Standard Biotools USD 41.64M 28.21M Mar/2026
Thermo Fisher Scientific USD 9.45B 247M Jun/2026
Waters USD 1.99B 228M Jun/2026
West Pharmaceutical Services USD 712M 26.4M Jun/2026